Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by DiaMedica Therapeutics Inc.
< Previous
1
2
Next >
DiaMedica Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 13, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Announces the Appointment of Biopharma Veteran Tanya Lewis to Its Board of Directors
March 06, 2023
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2022 Financial Results
November 09, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Attend the 13th Annual Craig-Hallum Alpha Select Conference November 17, 2022
November 07, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Present at Credit Suisse 31st Annual Healthcare Conference
October 31, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Provides Update on ReMEDy2 Trial
October 26, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Appoints Julie Daves as SVP, Clinical Development Operations
September 14, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Present at Lake Street’s 6th Annual Best Ideas Growth Conference
September 06, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2022 Financial Results
August 10, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Report Second Quarter 2022 Financial Results and Provide a Business Update August 11, 2022
August 04, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Participate in the BTIG Biotechnology Conference 2022
August 01, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2022 Financial Results
May 04, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business Update May 5, 2022
April 28, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Provides a Business Update and Announces Fourth Quarter 2021 Financial Results
March 14, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Announces Appointment of Dominic Cundari as Chief Commercial Officer
February 02, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Present Research at International Stroke Conference
January 25, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Appoints Dr. Kirsten Gruis as Chief Medical Officer
January 05, 2022
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Announces Participation in LifeSci Partners 11th Annual Corporate Access Event
December 13, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 17, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Provides a Business Update and Announces Third Quarter 2021 Financial Results
November 10, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Attend the 12th Annual Craig-Hallum Alpha Select Conference November 16, 2021
November 09, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Announces Addition of Stroke Recurrence as a Second Independent Primary Endpoint in ReMEDy2 Phase 2/3 AIS Trial
November 08, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Report Third Quarter 2021 Financial Results and Provide a Business Update November 11, 2021
November 04, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Announces Late Breaking Data from REDUX Phase 2 Trial to be Presented at ASN Kidney Week 2021
October 18, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Announces Fast Track Designation Granted to DM199 for the Treatment of Acute Ischemic Stroke
September 30, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Announces Closing of $30 Million Private Placement
September 28, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Announces $30 Million Private Placement
September 27, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Initiates Pivotal Trial of DM199 for the Treatment of Acute Ischemic Stroke
September 13, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics to Participate at Upcoming Investor Conferences
September 07, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
DiaMedica Therapeutics Provides a Business Update and Announces Second Quarter 2021 Financial Results
August 11, 2021
From
DiaMedica Therapeutics Inc.
Via
Business Wire
Tickers
DMAC
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.